Guinness Asset Management Ltd increased its stake in Danaher Corporation (NYSE:DHR) by 16.2% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 38,570 shares of the conglomerate’s stock after buying an additional 5,380 shares during the period. Guinness Asset Management Ltd’s holdings in Danaher Corporation were worth $3,255,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors also recently modified their holdings of DHR. Peddock Capital Advisors LLC boosted its stake in Danaher Corporation by 17.4% in the first quarter. Peddock Capital Advisors LLC now owns 1,224 shares of the conglomerate’s stock valued at $105,000 after buying an additional 181 shares during the last quarter. Proficio Capital Partners LLC boosted its stake in Danaher Corporation by 92.3% in the first quarter. Proficio Capital Partners LLC now owns 1,246 shares of the conglomerate’s stock valued at $105,000 after buying an additional 598 shares during the last quarter. ClariVest Asset Management LLC purchased a new stake in Danaher Corporation during the first quarter valued at approximately $157,000. Baystate Wealth Management LLC boosted its stake in Danaher Corporation by 3.3% in the first quarter. Baystate Wealth Management LLC now owns 1,900 shares of the conglomerate’s stock valued at $163,000 after buying an additional 60 shares during the last quarter. Finally, Cedar Wealth Management LLC boosted its stake in Danaher Corporation by 5.3% in the first quarter. Cedar Wealth Management LLC now owns 2,286 shares of the conglomerate’s stock valued at $196,000 after buying an additional 115 shares during the last quarter. Hedge funds and other institutional investors own 75.74% of the company’s stock.

Shares of Danaher Corporation (NYSE:DHR) traded down 0.613% during mid-day trading on Tuesday, reaching $81.865. 510,817 shares of the company were exchanged. The company has a market capitalization of $56.87 billion, a price-to-earnings ratio of 26.130 and a beta of 1.03. Danaher Corporation has a 12 month low of $75.71 and a 12 month high of $88.01. The firm’s 50-day moving average is $82.08 and its 200-day moving average is $84.16.

Danaher Corporation (NYSE:DHR) last posted its quarterly earnings data on Thursday, July 20th. The conglomerate reported $0.99 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.97 by $0.02. Danaher Corporation had a net margin of 12.63% and a return on equity of 11.15%. The business had revenue of $4.51 billion during the quarter, compared to analysts’ expectations of $4.50 billion. During the same quarter in the prior year, the business posted $0.90 earnings per share. Danaher Corporation’s revenue was up 6.3% compared to the same quarter last year. On average, equities analysts forecast that Danaher Corporation will post $3.95 earnings per share for the current fiscal year.

TRADEMARK VIOLATION NOTICE: “Guinness Asset Management Ltd Boosts Stake in Danaher Corporation (DHR)” was first posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this report on another site, it was stolen and reposted in violation of US & international copyright law. The legal version of this report can be accessed at https://www.thecerbatgem.com/2017/08/29/guinness-asset-management-ltd-boosts-stake-in-danaher-corporation-dhr.html.

Several analysts have commented on DHR shares. Credit Suisse Group reaffirmed a “buy” rating and issued a $93.00 target price on shares of Danaher Corporation in a research note on Wednesday, May 24th. Janney Montgomery Scott cut shares of Danaher Corporation from a “buy” rating to a “neutral” rating in a research note on Wednesday, June 7th. BidaskClub cut shares of Danaher Corporation from a “hold” rating to a “sell” rating in a research note on Thursday, June 15th. Zacks Investment Research cut shares of Danaher Corporation from a “hold” rating to a “sell” rating in a research note on Monday, June 19th. Finally, Deutsche Bank AG reaffirmed a “buy” rating and issued a $97.00 target price on shares of Danaher Corporation in a research note on Wednesday, June 21st. One investment analyst has rated the stock with a sell rating, three have given a hold rating, thirteen have assigned a buy rating and one has issued a strong buy rating to the company. The stock has an average rating of “Buy” and an average target price of $91.76.

In related news, Director Linda P. Hefner sold 10,578 shares of the company’s stock in a transaction dated Friday, July 21st. The shares were sold at an average price of $83.03, for a total transaction of $878,291.34. Following the completion of the sale, the director now owns 42,151 shares of the company’s stock, valued at $3,499,797.53. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Thomas Patrick Joyce, Jr. sold 9,772 shares of the company’s stock in a transaction dated Monday, July 31st. The stock was sold at an average price of $81.78, for a total transaction of $799,154.16. Following the sale, the insider now directly owns 155,520 shares of the company’s stock, valued at approximately $12,718,425.60. The disclosure for this sale can be found here. Insiders have sold 27,808 shares of company stock valued at $2,296,236 in the last ninety days. 12.20% of the stock is currently owned by company insiders.

About Danaher Corporation

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Institutional Ownership by Quarter for Danaher Corporation (NYSE:DHR)

Receive News & Stock Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related stocks with our FREE daily email newsletter.